Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960009/S545

Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)

Medtronic, Inc. · Decision date Nov 8, 2026

MEDTECHLEDGER EXPLANATIONP960009/S545

What did the FDA approve?

This supplement covers a change to the dimensions of a lead insertion tool associated with Medtronic’s deep brain stimulation system, together with a change to verification testing of the tool’s tip width.

FDA records S545 as a Real-Time Process supplement to PMA P960009. Its scope is the tool modification described in this filing; the system’s original approval is recorded separately under P960009.

FDA approval order statement

approval for dimensions size change for lead insertion tool and modification to tip width dimension verification testing.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Neurology
Decision date
Nov 8, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960009/S545
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
APPR
Decision date
Nov 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P960009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960009 · Original PMA

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  2. P960009/S545 received

    Application receipt date recorded by FDA.

  3. P960009/S546 · Related supplement

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  4. P960009/S542 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  5. P960009/S547 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)

  6. P960009/S548 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  7. P960009/S545 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960009

Explore the linked device profile

Other records with product code MHY

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 27, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records